New insights into developmental fate decisions by autoreactive CD4 thymocytes
Clinical and Translational Medicine · 2024
DOI: 10.1002/ctm2.1590 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Xuguang Tai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Thymocytes, CD4-Positive T-Lymphocytes, Cell Differentiation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural Research Program of the National Institutes of Health, National Cancer Institute Center for Cancer Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Alfred Singer
Förderung
- Intramural Research Program of the National Institutes of Health
- National Cancer Institute Center for Cancer Research
Zitieren
APA
Tai, X., & Singer, A. (2024). New insights into developmental fate decisions by autoreactive CD4 thymocytes. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1590
Vancouver
Tai X, Singer A. New insights into developmental fate decisions by autoreactive CD4 thymocytes. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1590
BibTeX
@article{Tai2024,
author = {Tai, Xuguang and Singer, Alfred},
title = {New insights into developmental fate decisions by autoreactive CD4 thymocytes},
journal = {Clinical and Translational Medicine},
year = {2024},
doi = {10.1002/ctm2.1590}
}
EUVIMED